Church & Dwight (NYSE:CHD) Price Target Raised to $120.00

Church & Dwight (NYSE:CHD) had its price objective boosted by research analysts at Oppenheimer from $110.00 to $120.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s target price points to a potential upside of 11.77% from the stock’s previous close.

Several other analysts have also recently commented on the stock. JPMorgan Chase & Co. boosted their price target on shares of Church & Dwight from $87.00 to $95.00 and gave the stock an “underweight” rating in a research note on Thursday, January 18th. TheStreet upgraded shares of Church & Dwight from a “c+” rating to a “b” rating in a research note on Friday, February 2nd. Bank of America boosted their price target on shares of Church & Dwight from $100.00 to $104.00 and gave the stock a “neutral” rating in a research note on Monday, April 15th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Church & Dwight from $109.00 to $112.00 and gave the stock a “buy” rating in a research note on Monday. Finally, UBS Group boosted their price target on shares of Church & Dwight from $99.00 to $105.00 and gave the stock a “neutral” rating in a research note on Monday, February 5th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $104.07.

Church & Dwight Price Performance

Shares of NYSE CHD opened at $107.36 on Tuesday. Church & Dwight has a twelve month low of $82.25 and a twelve month high of $107.56. The firm has a market cap of $26.19 billion, a P/E ratio of 35.32, a PEG ratio of 3.52 and a beta of 0.53. The company has a 50 day moving average of $102.54 and a 200 day moving average of $96.90. The company has a quick ratio of 0.64, a current ratio of 1.08 and a debt-to-equity ratio of 0.57.

Church & Dwight (NYSE:CHD) last posted its earnings results on Friday, February 2nd. The company reported $0.65 EPS for the quarter, hitting analysts’ consensus estimates of $0.65. Church & Dwight had a net margin of 12.88% and a return on equity of 20.28%. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter in the previous year, the firm posted $0.62 EPS. The firm’s revenue was up 6.4% on a year-over-year basis. As a group, research analysts expect that Church & Dwight will post 3.44 EPS for the current fiscal year.

Insider Activity at Church & Dwight

In other Church & Dwight news, EVP Barry A. Bruno sold 9,926 shares of the firm’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $104.55, for a total value of $1,037,763.30. Following the completion of the transaction, the executive vice president now owns 4,319 shares of the company’s stock, valued at $451,551.45. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, EVP Michael Read sold 4,500 shares of the stock in a transaction on Monday, March 11th. The shares were sold at an average price of $105.00, for a total value of $472,500.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Barry A. Bruno sold 9,926 shares of the stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $104.55, for a total transaction of $1,037,763.30. Following the completion of the sale, the executive vice president now owns 4,319 shares in the company, valued at approximately $451,551.45. The disclosure for this sale can be found here. Insiders sold 373,052 shares of company stock valued at $38,603,796 over the last 90 days. Insiders own 1.40% of the company’s stock.

Institutional Trading of Church & Dwight

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of Church & Dwight by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 30,265,072 shares of the company’s stock worth $2,861,865,000 after acquiring an additional 354,946 shares during the period. Capital International Investors grew its position in Church & Dwight by 39.2% during the fourth quarter. Capital International Investors now owns 9,004,713 shares of the company’s stock valued at $851,414,000 after buying an additional 2,533,877 shares during the period. Massachusetts Financial Services Co. MA grew its position in Church & Dwight by 2.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 8,200,426 shares of the company’s stock valued at $751,405,000 after buying an additional 217,047 shares during the period. JPMorgan Chase & Co. grew its position in Church & Dwight by 89.1% during the third quarter. JPMorgan Chase & Co. now owns 6,027,312 shares of the company’s stock valued at $552,283,000 after buying an additional 2,839,783 shares during the period. Finally, Stifel Financial Corp grew its position in Church & Dwight by 0.7% during the third quarter. Stifel Financial Corp now owns 4,310,580 shares of the company’s stock valued at $394,982,000 after buying an additional 29,943 shares during the period. Institutional investors and hedge funds own 86.60% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.